Mackenzie Financial »

Arcutis Biotherapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 49k 28.02

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Shopify Cl A Sub Vtg Shs (SHOP)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Canadian Natural Resources (CNQ)
Manulife Finl Corp (MFC)

View all positions for Mackenzie Financial

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
D. E. Shaw & Co
Ensign Peak Advisors
Franklin Resources

View all funds holding Arcutis Biotherapeutics